December 15, 2025 · Form 4 insider transaction
Shenouda Maged bought 11,665 shares of Relmada Therapeutics, Inc. at $4.12 per share, a transaction worth $48.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.